Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia 1Infections 1Hodgkin Disease 1

Interventions

Cyclophosphamide 47fludarabine phosphate 46Peripheral Blood Stem Cell Transplantation 36Tacrolimus 34Antilymphocyte Serum 33Busulfan 32Mycophenolic Acid 31Filgrastim 24Cyclosporine 24Radiotherapy 22Methotrexate 20Whole-Body Irradiation 18Methylprednisolone 18Melphalan 18Cord Blood Stem Cell Transplantation 14fludarabine 12Etoposide 11Granulocyte Colony-Stimulating Factor 8sargramostim 7Alemtuzumab 7Sirolimus 6Psychiatric Rehabilitation 6Flow Cytometry 6Cytarabine 6Rituximab 4Prednisone 4Polymerase Chain Reaction 4Immunologic Techniques 4thymoglobulin 3Thiotepa 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Plasma Cell × Nystatin × Myeloid × Clear all
NCT00002742 2013-03-26

Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer

National Cancer Institute (NCI)

Phase 3 Completed
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Infections, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡